The following is a summary of “A Novel Molecular Regulatory Network in Bone Marrow Mesenchymal Stem Cells for Age-Related Osteoporosis,” published in the March 2025 issue of Clinical Endocrinology by ...
Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.
BioRestorative also continues to explore a first-in-human clinical trial for its ThermoStem ® metabolic platform technology. The Company derived $300,000 in revenue from BioCosmeceuticals in 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback